TE
Tectonic Therapeutic, Inc. (TECX)
NASDAQ·Healthcare·Biotechnology
$28.83
-3.26%
Mkt Cap $596.46M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$67.50
Range $60.00 – $75.00
Implied Upside
+134.1%
Consensus $67.50 vs current $28.83